Pass Your Health Boards Pass Your Health Boards
Sanofi invests $1 billion to deepen Regeneron partnership, accelerating four next-gen antibody treatments inspired by Dupixent’s €15.7 billion…
Vance-led crackdown removes 750,000 from ACA plans, saving $2.2 billion by canceling subsidies and investigating eligibility.
FDA clears DreaMed’s MODI system, the first CGM-based tool for automated insulin dosing in Type 2 diabetes patients…
ADARx raises $535M in IPO for RNA-targeted therapies, advancing siRNA-based treatments to degrade disease-causing proteins.
Vance-led crackdown removes 750,000 from ACA plans, saving $2.2 billion by canceling subsidies and investigating eligibility.
Heart disease now kills more Hispanic adults in the U.S. than cancer, per 2022 data, challenging the 'Hispanic…
IL-17 inhibitors show low IBD risk in HS patients, according to a recent review in JAMA Dermatology.
Oncologists recognize AI's potential to enhance cancer care, yet only 19% utilize predictive models, revealing a significant implementation…
Drexel study finds three ways music relieves pain, offering new insights into music-based interventions for managing physical discomfort.
New research indicates a link between hidradenitis suppurativa and lymphoma risk. A 2019 study found patients were two…
Navitus launches flexible GLP-1 management programs for better therapy outcomes and cost management with GLP-1 therapies.
StarkRx, a pharmacy benefit management solution by Judi Health and Employers Health, offering cost-efficient, high-quality care.
The 2026 Consolidated Appropriations Act (CAA) will overhaul pharmacy pricing, impacting PBMs and payers.
Northwell reports a 75% rise in 9/11 cancer cases among Health Program patients, underscoring escalating health risks on…
